Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William Mattes

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Idrugs : the Investigational Drugs Journal|October 1, 2009
Drug Safety Strategies to De-Risk Compounds--an IBC conference. 4-6 August 2009, Boston, MA, USAWilliam Mattes
Archives of Toxicology|February 29, 2020
Determination of structural factors affecting binding to mu, kappa and delta opioid receptorsSvetoslav Slavov, William Mattes, Richard D Beger
Toxicology|February 19, 2008
Strategic paths for biomarker qualificationFederico M Goodsaid, Felix W Frueh, William Mattes
Drug Discovery Today. Technologies|July 2, 2014
The Predictive Safety Testing Consortium: A synthesis of the goals, challenges and accomplishments of the Critical PathFederico M Goodsaid, Felix W Frueh, William Mattes
Current Topics in Medicinal Chemistry|June 24, 2016
Molecular Docking for Identification of Potential Targets for Drug RepurposingHeng Luo, William Mattes, Donna L Mendrick, et al.
Advances in Clinical Chemistry|March 5, 2015
Biomarkers of tobacco smoke exposureWilliam Mattes, Xi Yang, Michael S Orr, et al.
Archives of Toxicology|May 21, 2018
Computational identification of structural factors affecting the mutagenic potential of aromatic amines: study design and experimental validationSvetoslav H Slavov, Iva Stoyanova-Slavova, William Mattes, et al.
BMC Bioinformatics|October 2, 2015
Understanding and predicting binding between human leukocyte antigens (HLAs) and peptides by network analysisHeng Luo, Hao Ye, Hui Ng, et al.
Biochemical and Biophysical Research Communications|May 27, 2025
Pexidartinib impairs liver mitochondrial functions causing cell death in primary human hepatocytes at clinically relevant concentrationsQiang Shi, Lijun Ren, Katy Papineau, et al.
Biomarkers in Medicine|October 27, 2015
microRNAs as pharmacogenomic biomarkers for drug efficacy and drug safety assessmentIgor Koturbash, William H Tolleson, Lei Guo, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Idrugs : the Investigational Drugs Journal|October 1, 2009
Drug Safety Strategies to De-Risk Compounds--an IBC conference. 4-6 August 2009, Boston, MA, USAWilliam Mattes
Archives of Toxicology|February 29, 2020
Determination of structural factors affecting binding to mu, kappa and delta opioid receptorsSvetoslav Slavov, William Mattes, Richard D Beger
Toxicology|February 19, 2008
Strategic paths for biomarker qualificationFederico M Goodsaid, Felix W Frueh, William Mattes
Drug Discovery Today. Technologies|July 2, 2014
The Predictive Safety Testing Consortium: A synthesis of the goals, challenges and accomplishments of the Critical PathFederico M Goodsaid, Felix W Frueh, William Mattes
Current Topics in Medicinal Chemistry|June 24, 2016
Molecular Docking for Identification of Potential Targets for Drug RepurposingHeng Luo, William Mattes, Donna L Mendrick, et al.
Advances in Clinical Chemistry|March 5, 2015
Biomarkers of tobacco smoke exposureWilliam Mattes, Xi Yang, Michael S Orr, et al.
Archives of Toxicology|May 21, 2018
Computational identification of structural factors affecting the mutagenic potential of aromatic amines: study design and experimental validationSvetoslav H Slavov, Iva Stoyanova-Slavova, William Mattes, et al.
BMC Bioinformatics|October 2, 2015
Understanding and predicting binding between human leukocyte antigens (HLAs) and peptides by network analysisHeng Luo, Hao Ye, Hui Ng, et al.
Biochemical and Biophysical Research Communications|May 27, 2025
Pexidartinib impairs liver mitochondrial functions causing cell death in primary human hepatocytes at clinically relevant concentrationsQiang Shi, Lijun Ren, Katy Papineau, et al.
Biomarkers in Medicine|October 27, 2015
microRNAs as pharmacogenomic biomarkers for drug efficacy and drug safety assessmentIgor Koturbash, William H Tolleson, Lei Guo, et al.
Pageof 2